Mathieu Rougemont
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard H, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stoeckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso R, Andre P, Girardin F, Guidi M, Buclin T, Decosterd L, Swiss HIV Cohort Study S. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. Lancet Reg Health Eur 2023; 36:100793.
13.12.2023Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
13.12.2023Lancet Reg Health Eur 2023; 36:100793
Thoueille Paul, Alves Saldanha Susana, Schaller Fabian, Choong Eva, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldyrich F, Kusejko Katharina, Surial Bernard, Furrer Hansjakob, Rauch Andri, Rougemont Mathieu, Ustero Pilar, Calmy Alexandra, Stoeckle Marcel, Marzolini Catia, Di Benedetto Caroline, Bernasconi Enos, Schmid Patrick, Piso Rein Jan, Andre Pascal, Girardin François R, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Swiss HIV Cohort Study SHCS
Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
Künzler-Heule P, Schmidt A, Fierz K, Battegay M, Engberg S, Kouyos R, Nöstlinger C, Stoeckle M, Béguelin C, Delaloye J, Schmid P, Rougemont M, Braun D, Fehr J, Nicca D. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care 2023:1-10.
14.05.2023Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
14.05.2023AIDS Care 2023:1-10
Künzler-Heule Patrizia, Schmidt Axel Jeremias, Fierz Katharina, Battegay Manuel, Engberg Sandra J, Kouyos Roger D, Nöstlinger Christiana, Stoeckle Marcel, Béguelin Charles, Delaloye Julie, Schmid Patrick, Rougemont Mathieu, Braun Dominique Laurent, Fehr Jan S, Nicca Dunja
A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study
Braun D, Schmid P, Rougemont M, Delaloye J, Bernasconi E, Nicca D, Böni J, Rauch A, Kouyos R, Günthard H, Béguelin C, Stöckle M, Hampel B, Ledergerber B, Grube C, Nguyen H, Künzler-Heule P, Shah C, Salazar-Vizcaya L, Conen A, Flepp M, Fehr J. A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study. Clin Infect Dis 2020
06.08.2020A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study
06.08.2020Clin Infect Dis 2020
Braun Dominique L, Schmid Patrick, Rougemont Mathieu, Delaloye Julie, Bernasconi Enos, Nicca Dunja, Böni Jürg, Rauch Andri, Kouyos Roger D, Günthard Huldrych F, Béguelin Charles, Stöckle Marcel, Hampel Benjamin, Ledergerber Bruno, Grube Christina, Nguyen Huyen, Künzler-Heule Patrizia, Shah Cyril, Salazar-Vizcaya Luisa, Conen Anna, Flepp Markus, Fehr Jan S
High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men
Braun D, Fehr J, Böni J, Günthard H, Rauch A, Bernasconi E, Rougemont M, Delaloye J, Schmid P, Béguelin C, Conen A, Stöckle M, Flepp M, Grube C, Kusejko K, Kouyos R, Martin E, Hampel B, Swiss HIV Cohort Study. High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men. Clin Infect Dis 2018
13.08.2018High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men
13.08.2018Clin Infect Dis 2018
Braun Dominique L, Fehr Jan S, Böni Jürg, Günthard Huldrych F, Rauch Andri, Bernasconi Enos, Rougemont Mathieu, Delaloye Julie, Schmid Patrick, Béguelin Charles, Conen Anna, Stöckle Marcel, Flepp Markus, Grube Christina, Kusejko Katharina, Kouyos Roger, Martin Eileen, Hampel Benjamin, Swiss HIV Cohort Study
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
Braun D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Böni J, Fehr J, Nicca D, Künzler-Heule P, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Swiss HIV Cohort Study. High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men. Clin Infect Dis 2018
13.08.2018High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
13.08.2018Clin Infect Dis 2018
Braun Dominique L, Schmid Patrick, Delaloye Julie, Rougemont Mathieu, Bernasconi Enos, Rauch Andri, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Nicca Dunja, Künzler-Heule Patrizia, Hampel Benjamin, Kouyos Roger, Nguyen Huyen, Shah Cyril, Flepp Markus, Stöckle Marcel, Conen Anna, Béguelin Charles, Swiss HIV Cohort Study
Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
Salazar-Vizcaya L, Rauch A, Béguelin C, Rougemont M, Hoffmann M, Bernasconi E, Stoeckle M, Cavassini M, Braun D, Fehr J, Wandeler G, Swiss HIV Cohort Study. Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study. Open Forum Infect Dis 2018; 5:ofy154.
26.06.2018Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
26.06.2018Open Forum Infect Dis 2018; 5:ofy154
Salazar-Vizcaya Luisa, Rauch Andri, Béguelin Charles, Rougemont Mathieu, Hoffmann Matthias, Bernasconi Enos, Stoeckle Marcel, Cavassini Matthias, Braun Dominique, Fehr Jan, Wandeler Gilles, Swiss HIV Cohort Study
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study
Béguelin C, Rauch A, Wandeler G, Schmid P, Rougemont M, Cavassini M, Stoeckle M, Bucher H, Kovari H, Fehr J, Bernasconi E, Suter A, Swiss HIV Cohort Study. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver Int 2017
25.07.2017Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study
25.07.2017Liver Int 2017
Béguelin Charles, Rauch Andri, Wandeler Gilles, Schmid Patrick, Rougemont Mathieu, Cavassini Mathias, Stoeckle Marcel, Bucher Heiner C, Kovari Helen, Fehr Jan, Bernasconi Enos, Suter Annatina, Swiss HIV Cohort Study
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study
Kovari H, Ledergerber B, Weber R, Bernasconi E, Stöckle M, Schmid P, Cavassini M, Rougemont M, Kouyos R, Rauch A, Swiss HIV Cohort Study. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study. Clin Infect Dis 2017; 64:490-497.
15.01.2017Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study
15.01.2017Clin Infect Dis 2017; 64:490-497
Kovari Helen, Ledergerber Bruno, Weber Rainer, Bernasconi Enos, Stöckle Marcel, Schmid Patrick, Cavassini Matthias, Rougemont Mathieu, Kouyos Roger, Rauch Andri, Swiss HIV Cohort Study
Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study
Kovari H, Ledergerber B, Weber R, Bernasconi E, Stöckle M, Schmid P, Cavassini M, Rougemont M, Kouyos R, Rauch A. Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. Clin Infect Dis 2016
12.12.2016Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study
12.12.2016Clin Infect Dis 2016
Kovari Helen, Ledergerber Bruno, Weber Rainer, Bernasconi Enos, Stöckle Marcel, Schmid Patrick, Cavassini Matthias, Rougemont Mathieu, Kouyos Roger, Rauch Andri
CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
Sauter R, Held L, Günthard H, Rougemont M, Hoffmann M, Furrer H, Cavassini M, Bernasconi E, Battegay M, Ledergerber B, Huang R. CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART. Medicine (Baltimore) 2016; 95:e5094.
28.10.2016CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
28.10.2016Medicine (Baltimore) 2016; 95:e5094
Sauter Rafael, Held Leonhard, Günthard Huldrych F, Rougemont Mathieu, Hoffmann Matthias, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Ledergerber Bruno, Huang Ruizhu
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
Shilaih M, Kouyos R, Günthard H, Hirzel C, Bernasconi E, Hoffmann M, Battegay M, Darling K, Rougemont M, Kovari H, Braun D, Scherrer A, Marzel A. Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis. J Infect Dis 2016; 214:599-606.
18.05.2016Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
18.05.2016J Infect Dis 2016; 214:599-606
Shilaih Mohaned, Kouyos Roger D, Günthard Huldrych F, Hirzel Cédric, Bernasconi Enos, Hoffmann Matthias, Battegay Manuel, Darling Katharine, Rougemont Mathieu, Kovari Helen, Braun Dominique L, Scherrer Alexandra U, Marzel Alex
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
Boillat-Blanco N, Cavassini M, Günthard H, Furrer H, Clerc O, Aouri M, Bernasconi E, Fulchini R, Rougemont M, Vuichard D, Schöni-Affolter F, Darling K, the Swiss HIV Cohort Study. Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antivir Ther (Lond) 2014
25.06.2014Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
25.06.2014Antivir Ther (Lond) 2014
Boillat-Blanco Noémie, Cavassini Matthias, Günthard Huldrych F, Furrer Hansjakob, Clerc Olivier, Aouri Manel, Bernasconi Enos, Fulchini Rosamaria, Rougemont Mathieu, Vuichard Danielle, Schöni-Affolter Franziska, Darling Katharine Ea, the Swiss HIV Cohort Study